Tv Connectée 80 Cm Electro Dépôt

• Finance
• Watchlists
• My Portfolio
• Cryptocurrencies
• Yahoo Finance Plus
• Screeners
• Markets
  • Options: Highest Open up Involvement
    Options: Highest Open Interest
  • Options: Highest Implied Volatility
    Options: Highest Implied Volatility
• News
• Personal Finance
• Videos
  • Influencers with Andy Serwer
    Influencers with Andy Serwer
  • Yahoo Finance All Markets Tiptop
    Yahoo Finance All Markets Top
  • America: Back in Business
    America: Back in Business
• Yahoo U
• Industries
• Tech
• Contact United states

• S&P 500

• Dow 30

• Nasdaq

• Russell 2000

• Crude Oil

• Gold

• Silver

• EUR/USD

• 10-Yr Bond

• GBP/USD

• USD/JPY

• BTC-USD

• CMC Crypto 200

• FTSE 100

• Nikkei 225

InspireMD Commences Trading on Nasdaq-CM

Ticker to remain NSPR

TEL AVIV, Israel, May 21, 2021 (World NEWSWIRE) -- InspireMD, Inc. (Nasdaq-CM: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke acquired by Carotid Artery Affliction (CAD), today announced that the Company'southward shares volition commence trading on The Nasdaq Majuscule Market place ("Nasdaq-CM"), today, May 21, 2021, nether the symbol NSPR.

InspireMD CEO Marvin Slosman said, "The trading of our shares on the Nasdaq Capital Market place is a even so another very important step in the connected evolution of InspireMD as we seek to create improved awareness of the Company, broaden our shareholder base of operations, and amend trading liquidity in our efforts to establish a new standard of care in the treatment of carotid artery disease and stroke prevention."

About InspireMD, Inc.

InspireMD seeks to utilize its proprietary MicroNet® technology to make its products the manufacture standard for carotid stenting by providing outstanding acute results and durable, stroke-gratuitous, long-term outcomes.

Forward-looking Statements

This press release contains "forward-looking statements." Such statements may exist preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Forrad-looking statements are not guarantees of futurity performance, are based on sure assumptions and are subject to diverse known and unknown risks and uncertainties, many of which are across the Visitor'south control, and cannot exist predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forrard-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) market place credence of our existing and new products, (ii) negative clinical trial results or lengthy production delays in fundamental markets, (three) an disability to secure regulatory approvals for the sale of our products, (iv) intense contest in the medical device industry from much larger, multinational companies, (v) product liability claims, (vi) production malfunctions, (vii) our limited manufacturing capabilities and reliance on subcontractors for assistance, (viii) insufficient or inadequate reimbursement by governmental and other third party payers for our products, (nine) our efforts to successfully obtain and maintain intellectual property protection covering our products, which may not be successful, (x) legislative or regulatory reform of the healthcare system in both the U.S. and foreign jurisdictions, (xi) our reliance on single suppliers for sure production components, (xii) the fact that we volition need to raise additional capital to meet our business requirements in the future and that such capital raising may be costly, dilutive or difficult to obtain and (xiii) the fact that we conduct business in multiple foreign jurisdictions, exposing us to foreign currency substitution rate fluctuations, logistical and communications challenges, burdens and costs of compliance with strange laws and political and economic instability in each jurisdiction. More detailed information about the Visitor and the risk factors that may touch on the realization of forrard-looking statements is set forth in the Visitor's filings with the Securities and Exchange Commission (SEC), including the Company's Annual Study on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC's spider web site at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forrad-looking statements as a event of new information, future events or otherwise.

Investor Contacts:

Craig Shore
Chief Financial Officeholder
InspireMD, Inc.
888-776-6804
craigs@inspiremd.com

CORE IR
investor-relations@inspiremd.com

• 

  Where Will the Comport Market place Bottom? ii Valuation-Based Indicators Offer a Clear Range

  The beginning half of the year saw the benchmark Southward&P 500 (SNPINDEX: ^GSPC) produce its worst render since 1970. With the S&P 500 and Nasdaq respectively failing 24% and 34%, respectively, at their peaks, both indexes have firmly entered deport market territory. Given the heightened volatility and doubtfulness that accompanies bear markets, it has a lot of investors wondering where the market volition bottom.

• 

  AdIt's Never Too Tardily for Love!

  Safe, Secure Dating for Mature Singles. Build Connections & Find Honey. Conversation At present!

• 
• 
• 

  Why Nvidia's New Lovelace Flake Is Bad News for Jay Powell

  Concluding week, Nvidia (NASDAQ: NVDA) unveiled its new RTX graphics fries based on its "Lovelace" architecture. The chips take some impressive operation metrics, making an exciting jump forward in operation over the prior Ampere generation. The highest-end RTX Lovelace 4090 graphics cards will retail for $i,599, and the 4080 cards will become for a lower range, between $899 and $ane,199.

• 

  AdvertizementExport Rock Crushers to Republic of indonesia

  Big Output Mobile Crusher. Loftier Output and Reliability. For Ore/Stone/Mineral Burdensome. Cases in 160+ Countries. Splendid Stone Crusher Manufacturer

• 

  3 Growth Stocks Downwardly 54% to 84% That You Tin can Purchase and Hold Forever

  Cathie Forest's Ark Innovation ETF, which focuses on such stocks, has plunged by nearly 75% from its early on 2021 peak, and some individual companies have fallen further. Advanced Micro Devices (NASDAQ: AMD),  Meta Platforms (NASDAQ: META), and Twilio (NYSE: TWLO) are likely three such stocks. Jake Lerch (Avant-garde Micro Devices): There's plenty of carnage in the stock market amid tech stocks, and AMD is no exception.

• 

  The Corking Bond Bubble Is 'Poof, Gone' in Worst Yr Since 1949

  (Bloomberg) -- Week by calendar week, the bond-market crash just keeps getting worse and at that place's no clear end in sight.Most Read from BloombergBank of England Says Paper Banknotes Only Skilful for One More Calendar week'Read Putin More than Often and Carefully,' Lavrov Tells the WorldThe Great Bail Chimera Is 'Poof, Gone' in Worst Year Since 1949UK Market place Plunge Sparks Talk of Emergency BOE Rate HikeWith central banks worldwide aggressively ratcheting upwardly interest rates in the face of stubbornly loftier inflation, prices are

• 

  AdHuman being Finds Tiny Creature In Backyard

  You'll Never Believe What It Grew Into...

• 

  Advertizing12 Foods You lot Can Eat a Lot of Without Getting Fat

  List Of Salubrious Foods Yous Can Eat Without Gaining Whatsoever Weight

• 

  Better Dividend Stock: AT&T vs. IBM

  AT&T (NYSE: T) and IBM (NYSE: IBM) both underwent dramatic transformations over the past year. AT&T divested DirecTV, merged WarnerMedia with Discovery to create Warner Bros. Discovery (NASDAQ: WBD) , and sold many of its non-core avails to prioritize the growth of its core telecom business.

• 

  Why Warren Buffett Doesn't Buy Real Estate And Well-nigh Other Investors Shouldn't Either

  Warren Buffett'southward long-term investment strategy has proven to be successful through well-nigh all market conditions over the by several decades – recession, high inflation and deflation. If there'southward one thing that'due south made Buffett one of the well-nigh successful investors in history, information technology'due south his commitment to his strategy. A countless number of new investment techniques and algorithms have come up and gone over the years, but Buffett has maintained his relatively unproblematic strategy of picking solid companies an

• 
• 

  2 Pot Stocks That Could Make You lot Richer

  Simply well-nigh all growth stocks were hammered this year. Since they peaked in the outset quarter of 2021, the lack of favorable momentum toward U.S. federal legalization has taken a major toll on their stock prices. But these companies are growing revenue at a healthy rate that could brand them elevation cannabis players by the time U.S. federal legalization happens.

• 

  AdAlways Put A Crayon In Your Wallet When Traveling

  I was all ready for my trip, or and so I thought. That's when my friend told me to place a crayon in my wallet when traveling. The reason is quite clever.

• 

  With Apple Threatening, Is Information technology Time to Sell Garmin?

  Garmin (NYSE: GRMN) stock has had a rough 2022 already, and shares caught additional pressure level recently thanks to news out of Apple (NASDAQ: AAPL). The consumer tech giant already competes confronting some of Garmin's popular smartwatch devices, but that competition is hit a new level. Apple announced a new add-on to its smartwatch lineup that's aimed at sports enthusiasts and includes many of the navigation features that take been a staple of Garmin products, similar its tactix adventure watch.

• 

  Novavax Downgraded by JPMorgan Hunt. Fourth dimension to Sell?

  The Novavax (NASDAQ: NVAX) rollercoaster has been a wild ane. The stock soared more than than 2,700% in 2020 after the visitor received $1.6 billion from the U.S. government to develop the COVID-19 vaccine we now know as Nuvaxovid. Unfortunately, Novavax didn't receive say-so to sell its vaccine in the U.S. until this July.

Tv Connectée 80 Cm Electro Dépôt,

Source: https://finance.yahoo.com/news/inspiremd-commences-trading-nasdaq-cm-123000911.html

Posted by: rayrectly.blogspot.com

Share this post